Home » Newsletters » BioWorld Science

BioWorld Science

Nov. 20, 2007

View Archived Issues

Primate studies elucidate activity of novel small-molecule, cholesterol-lowering agents

Vasohibin beneficial in early diabetic nephropathy model

A TGF-beta inhibitor protects against radiation-induced lung damage

Insmed positioned to initiate clinical studies of follow-on biologics products

Cardium initiates phase IIb MATRIX clinical study of Excellarate for diabetic ulcers

Pharmacological interventions for hepatic pathologies discussed at Liver Meeting

Merck Serono extends rights to Rigel's R-763/AS-703569 to include Japan

Advanced Life Sciences reports positive results from Trial CL-05 of cethromycin

BioLineRx enters worldwide license agreement with Yissum and Hadasit for BL-4060

Nymox completes 2-year follow-up study of NX-1207 for benign prostatic hyperplasia

Novartis initiates phase II study of QVA-149 for chronic obstructive pulmonary disease

Panacea makes CC Detect available as diagnostic test for colon cancer

Introgen reports summary data from clinical studies of p53 tumor suppressor Advexin

HealthLinx successfully completes phase II biomarker trial on the OvPlex panel

Innovive initiates STAR-1 phase II clinical trial of tamibarotene

Cogentus initiates phase III clinical trials of CGT-2168 in antiplatelet therapy

Novel antiobesity agents described in recent patent literature

Genta reports positive data from phase I clinical trial of G-4544 for accelerated bone loss

Taisho reports on novel antagonists of the MCH receptor 1

FDA authorizes IND for Athersys' MultiStem for bone marrow transplant support

LipoNova confirms U.S. and E.U. registration strategy for renal cell cancer vaccine Reniale

Adventrx meets primary endpoint in bioequivalence clinical study of ANX-530

FDA accepts Discovery Laboratories' response to approvable letter for Surfaxin

Thallion reports positive safety and efficacy data from phase I/II trial of ECO-4601

Gilead submits NDA to FDA for aztreonam lysine for inhalation for cystic fibrosis

CHMP adopts negative opinion on marketing authorization for Tysabri for Crohn's disease

FDA approves supplemental NDA for Nexavar for unresectable hepatocellular carcinoma

CHMP recommends extended indication for Angiox for acute coronary syndromes

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 8, 2026.
ASCO 2026: Chinese biopharma arrives at ASCO with pivotal wins
BioWorld
If the 2026 American Society of Clinical Oncology (ASCO) annual meeting in Chicago from May 30 to June 3 demonstrated anything about the evolution of China’s...
New York University identifies new analogues of mannose-6-phosphate
BioWorld Science
New York University has discovered new analogues of mannose-6-phosphate reported to be potentially useful for the treatment of memory impairment,...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 9, 2026
Skape Bio unlocks GPCR targets with de novo-designed miniproteins
BioWorld
Modulating G protein-coupled receptors (GPCRs) is one of the major challenges in biomedicine. These are flexible proteins with small, deep binding pockets. The...